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Background: Clinical microbiology laboratories have to accurately identify clinical microbes. However, some
isolates are difficult to identify by the automated biochemical text platforms, which are called “difficult-to-identify”
microbes in this study. Therefore, the ability of 16S ribosomal DNA (16S rDNA) and internal transcribed spacer 2
(ITS2) sequencing to identify these “difficult-to-identify” bacteria and fungi was assessed in this study.
Methods: Samples obtained from a teaching hospital over the past three years were examined. The 16S rDNA of
four standard strains, 18 clinical common isolates, and 47 “difficult-to-identify” clinical bacteria were amplified by
PCR and sequenced. The ITS2 of eight standard strains and 31 “difficult-to-identify” clinical fungi were also amplified
by PCR and sequenced. The sequences of 16S rDNA and ITS2 were compared to reference data available in
GenBank by using the BLASTN program. These microbes were identified according to the percentage of similarity
to reference sequences of strains in GenBank.
Results: The results from molecular sequencing methods correlated well with automated microbiological
identification systems for common clinical isolates. Sequencing results of the standard strains were consistent with
their known phenotype. Overall, 47 “difficult-to-identify” clinical bacteria were identified as 35 genera or species by
sequence analysis (with 10 of these identified isolates first reported in clinical specimens in China and two first
identified in the international literature). 31 “difficult-to-identify” clinical fungi tested could be identified as 15
genera or species by sequence analysis (with two of these first reported in China).
Conclusions: Our results show the importance of 16S rDNA and internal ITS2 sequencing for the molecular identification
of “difficult-to-identify” bacteria and fungi. The development of this method with advantages of convenience, availability,
and cost-effectiveness will make it worth extending into clinical practice in developing countries.
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In clinical microbiology laboratories, traditional culture and
biochemical techniques remain the primary methodology
for identifying most pathogens. With the development
of technology, automated microbiology system for the
identification of pathogens has been introduced in many
laboratories. In recent years, with the population aging, the
number of patients with organ transplantation and bone
marrow transplantation increasing, and immunosuppressive* Correspondence: yongyuruigroup@sina.com
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stated.agents, anticancer drugs and invasive detection and
treatment widely used, more and more patients suffer
from severe infection of bacteria or fungi. Many clinical iso-
lates from these patients can be identified by the automated
biochemical text platforms in the most of laboratories.
However, some isolates are difficult to identify by those
platforms, which are called “difficult-to-identify” microbes
in this study. Therefore, it is important to establish
molecular diagnostic techniques for the identification
of “difficult-to-identify” bacteria and fungi from clinical
isolates.
Ribosomal genes encoding rRNA are present in the
chromosomes of all prokaryotes and eukaryotes. InLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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identification has the potential to enable the identification
of specific bacteria due to the universal distribution of 16S
rDNA among bacteria and the presence of several special
variable regions. The identification of organisms by sequen-
cing DNA encoding 16S rRNA has been described in case
reports that focus on the identification of different bacterial
species or genera [1-4]. The internal transcribed spacer
(ITS) region, ITS1-5.8-ITS2, located between the 18S and
28S rRNA genes and the 5.8S rRNA gene, have proved suf-
ficient for the discrimination of most species of clinically
important fungi. ITS regions, especially ITS2, have emerged
as the most common target of molecular-based identifica-
tion [5,6]. The development of an inexpensive and efficient
application of molecular identification procedures would
help with the clinical identification of “difficult-to-identify”
bacteria and fungi according to 16S rRNA and ITS2
sequences.
Molecular identification methods, in which the partial
sequence of 16S rDNA or ITS2 were sequenced and
analyzed, were established in standard strains and clinical
common isolates (including bacteria and fungi) in this
study. In addition, isolates unidentified by routine laboratory
procedures in our laboratory over the past 3 years were
identified by these molecular methods.
Methods
Bacterial and fungal isolates
Bacterial and fungal isolates were obtained from the
Laboratory Medicine Center of Nanfang hospital, a 2,200-
bed university-affiliated tertiary-care institution. This labora-
tory routinely processes human samples for culture-based
diagnosis of bacterial and fungal infectious diseases, in-
cluding those due to anaerobes, aerobes, Mycobacteria,
Candida, Aspergillus, and other isolates. All fungal isolates
were isolated from deep mycosis. Conventional laboratory
techniques for phenotyping were carried out on all isolates
according to BD Phoenix 100 Automated Microbiology
System (Becton, Dickinson and Co., Franklin Lakes, NJ)
and MicroScan WalkAway® 96 plus System (Siemens
Healthcare Diagnostics Inc., West Sacramento, CA). In
this study, 78 “difficult-to-identify” microbes (including
47 bacteria and 31 fungi) from our laboratory were obtained
from blood, puncture fluid, secretions, sputum and urine.
All these isolates were difficult to identify by the auto-
mated biochemical text platforms in our laboratory during
the past three years. Staphylococcus aureus ATCC29213,
Escherichia coli ATCC25922, Pseudomonas aeruginosa
ATCC27853, Mycobacterium tuberculosis H37Rv, Candida
albicans ATCC90029, Candida tropicalis ATCC13803,
Candida glabrata ATCC15126, Candida parapsilosis
ATCC22019, Aspergillus fumigatus ATCC96918, Aspergillus
flavus ATCC28539, Aspergillus terreus ATCC1012, Asper-
gillus niger ATCC16404, and other clinically commonspecies were used as controls in this study. The study was
approved by Medical Ethics Committee Nanfang Hospital
Southern Med. Univ. and conducted in compliance with
the Declaration of Helsinki.
DNA extraction
Extraction of nucleic acids was carried out using a Lysis
Buffer for Microorganism to Direct PCR kit (TaKaRa Bio
Inc., Tokyo, Japan), supplemented by the TaKaRa MiniBEST
Universal Genomic DNA Extraction Kit Ver.5.0 (TaKaRa),
according to the manufacturer’s instructions. Colonies
required collection from fresh culture in blood plates or
Sabouraud’s media for bacteria and fungi, respectively.
The concentration of colonies and hyphae in lysis buffer
should also be within an appropriate range (visible
turbidity). DNA previously extracted was directly ampli-
fied by PCR.
16S rDNA gene sequencing
The 16S rRNA genes were amplified from previous
bacterial DNA using conventional PCR with primers
16S-F (5′-CCAGCAGCCGCGGTAATACG-3) and 16S-R
(5′-ATCGG (C/T) TACCTTGTTACGACTTC-3′) [7],
producing an amplicon of about 996 bp. PCR amplifi-
cations were performed using 5 L of template, 5 L of
10 × PCR buffer, 4 M of each primer stock solution,
4 mM of each dNTP, 1.25 U of ex Taq DNA polymerase
(TaKaRa), and sterile distilled water added to a final total
volume of 50 L. Amplification was performed using a
Mastercycler® PCR System (Eppendorf International,
Hamburg, Germany). Thermocycling parameters were
94°C for 10 min, 35 cycles of 94°C for 30 s, 55°C for
1 min, and 72°C for 2 min; a final extension step at 72°C
was added for 5 min. The products of PCR amplification
were examined by gel electrophoresis [100 V through a
1.5% agarose gel with 0.5 × TBE (Tris-borate-EDTA)
running buffer], stained with ethidium bromide, and
analyzed with the GelDoc XR Gel Documentation System
(Bio-Rad, USA.). PCR amplicon sizes were estimated
by comparison to molecular size markers (TaKaRa) then
purified and sequenced (Sanger capillary sequencing) at the
Beijing Genomics Institute (Shenzhen, China).
ITS2 sequencing
The ITS2 regions were amplified from the previous fungi
DNA using conventional PCR with primers ITS86-F
(5′-GTGAATCATCGAATCTTTGAAC-3′) and ITS4-R
(5′-TCCTCCGCTTATTGATATGC-3′) [8], producing an
amplicon of approximately 200 ~ 400 bp. The PCR reaction
mix, except for the primers, contained the same ingredients
described above. Thermal cycling parameters were 10 min
at 94°C, 30 cycles of 30 s at 94°C, 40 s at 55°C, and 1 min at
72°C; a final extension step at 72°C was added for 5 min.
The products from PCR amplification were examined by
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quencing and analysis steps were performed as previously
described.
Sequence analysis
DNA sequences obtained were analyzed for homology
using the BLASTN program at the National Center for
Biotechnology Information website (http://blast.ncbi.nlm.
nih.gov/Blast.cgi). Species and genera identification
were presumed for clinical bacteria with a percent
similarity of ≥99% and ≥97% [9], respectively, to reference
sequences of strains in GenBank. Meanwhile, if % ID ≥
99%, the highest E-value and % ID were taken as the cri-
teria to identify the isolates. In addition, the strain was just
identified as the level of genus when its result of the
BLASTN showed more than two species in the same
genus with % ID ≥99%. A <97% identity indicated the iso-
late as a potentially new species.
The sequence of a fungus was assigned to a species if the
best matching reference sequence showed ≥98% homology
and to a genus level on the basis of 95 to 98% homology
to the best matching sequence or of ≥98% homology with
sequence entries for several species from the same genus.
“No identification” was defined as <95% homology with
the best matching reference sequence [10].
Results
Identification of bacteria by 16S rDNA sequence analysis
The 16 s rRNA amplicons of some isolates including
5 standard strains and clinical isolates showed on electro-
pherograms (Figure 1). Sequencing results of the standard
strains were consistent with the known phenotype. The clin-
ically common isolates used in the study were Staphylococ-
cus epidermidis, Staphylococcus haemolyticus, Enterococcus
faecium, Enterococcus faecalis, Streptococcus agalactiae,
Streptococcus pneumonia, Streptococcus pyogenes, Kleb-
siella pneumoniae, Enterobacter cloacae, Enterobacter aero-
genes, Proteus mirabilis, Serratia marcescens, AcinetobacterFigure 1 Bacterial 16S rDNA PCR products of agarose gel
electrophoresis. The following DNA templates were used for PCR
(by lane): 1, Staphylococcus aureus ATCC29213; 2, Enterococcus
faecalis; 3, Enterococcus faecium; 4, Streptococcus pneumoniae; 5,
Streptococcus pyogenes; 6, Escherichia coli ATCC25922; 7, Klebsiella
pneumoniae; 8, Pseudomonas aeruginosa ATCC27853; 9, Acinetobacter
baumannii; 10, Bacteroides fragilis; 11, Mycobacterium tuberculosis
H37Rv; 12, Candida albicans ATCC 90029; 13, human leucocyte.baumannii, Pseudomonas aeruginosa, Pseudomonas malto-
philia, Burkholderia cepacia, Aeromonas hydrophila and
Flavobacterium indologenes. Sequencing results of these
isolate were consistent with the phenotypic identification
by the automated microbiology system.
A total of 47 “difficult-to-identify” bacterial isolates,
including 22 Gram-negative bacteria, 23 Gram-positive
and two acid-fast bacilli were analyzed by 16S rDNA
PCR and sequencing. Sequencing identified 30 isolates as
25 species and the remaining 17 isolates as ten genera
(Table 1). In these results, 10 isolates were first reported
from clinical specimens in China and two were first
reported in the international literatures.
Identification of clinical isolates by ITS2 sequence analysis
Electropherograms in Figure 2 shows the result of PCR
amplicons from the ITS2 region including four eight
standard strains and 3 “difficult-to-identify” isolates. The
identification of these standard strains by sequencing was
consistent with their phenotype.
A total of 31 “difficult-to-identify” fungal isolates from
various clinical specimens were analyzed by ITS2 PCR
and sequencing. Sequencing identified these isolates as
15 different genera or species (Table 2). Of these clinical
fungi isolates, 27 isolates were identified as 13 species
and 5 were identified as two genera. Two isolates were
first reported from clinical specimens in China.
Discussion
Most isolates recovered in our laboratory are identified
by phenotypic criteria with an automated microbiology
system, which likely reflects the present situation at
most teaching hospital laboratories worldwide. It is well
known that the microbiology systems from Siemens
MicroScan WalkAway 96 plus System, BD Phoenix 100
Automated Microbiology System and BioMerieux Vitek
2 Compact have been extensively applied clinically in
different regions. However, some isolates that are uncom-
mon or atypical clinically have difficulty in identifying by
the above systems. Genetic methods for the identification
and taxonomic classification of microorganisms have
thus been established in clinical microbiology laboratories
in recent years.
The sequence analysis of 16S rDNA is the most common
molecular method for the identification of bacteria [11],
but most studies have mainly focused on method develop-
ment and anecdotal case reports. On the basis of key
reports and previous clinical work, we selected a set of
universal reference primers to amplify 16S rDNA and
identify previously “difficult-to-identify” bacteria in clinical
settings. In addition, the ITS region (especially ITS2) is
heavily used for the identification of fungi [12]. The identi-
fication of standard strains and common clinical isolates
by PCR and sequencing in this study demonstrates that
Table 1 16S rDNA-based identification of a collection of 47 “difficult-to-identify” bacteria clinical isolates
Genus/strain No. of isolates Source of isolates GenBank accession no. BLAST
E-value % ID
Gram-negative 22
Acinetobacter johnsonii 1 Secretion KF381212 0.0 100
Aggregatibacter aphrophilus 1 Blood KF410885 0.0 100
Agrobacterium tumefaciensa 1 Blood JF487939 0.0 100
Bacteroides fragilis 1 Blood KF381209 0.0 100
Bilophila wadsworthiaa, 1 Pleural fluid KF414628 0.0 99
Campylobacter fetus 1 Blood KF372434 0.0 100
Capnocytophaga sputigenaa 3 Blood, secretion JF422019 0.0 99
Delftia sp. 1 Puncture fluid KF410887 0.0 –c
Dialister pneumosintesa 1 Cerebrospinal fluid KF410890 0.0 100
Eikenella corrodens 1 Blood KF372435 0.0 100
Enterobacter sp. 1 Blood KC148534 0.0 –c
Haemophilus influenzae 1 Blood JF487936 0.0 100
Massilia sp.a 1 Puncture fluid KF410886 0.0 100
Moraxella osloensis 3 Blood, secretion KF372432 0.0 100
Neisseria meningitidis 2 Cerebrospinal fluid, blood KF372431 0.0 99
Pontibacter sp.b 1 Puncture fluid KF410889 0.0 –c
Prevotella bivia 1 Secretion KF372433 0.0 99
Gram-positive 23
Bacillus amyloliquefaciens 1 Puncture fluid KF410881 0.0 99
Bacillus niabensisb 1 Puncture fluid KF381217 0.0 100
Bacillus pumilus 1 Secretion KF381216 0.0 99
Brachybacterium sp. 1 Secretion KF410892 0.0 –c
Corynebacterium amycolatum 1 Blood JF487935 0.0 99
Corynebacterium falsenii 1 Blood KF414626 0.0 100
Corynebacterium sp. 2 Blood, secretion KF414627 0.0 –c
Corynebacterium xerosis 1 Blood KF410882 0.0 100
Granulicatella adiacens 1 Blood KF381213 0.0 100
Janibacter sp.a 1 Blood KF410884 0.0 –c
Leifsonia sp.a 2 Blood KF410883 0.0 –c
Nocardia sp. 6 Secretion KF381210 0.0 –c
Paenibacillus massiliensisa 1 Puncture fluid KF381215 0.0 100
Propionibacterium acnes 1 Blood KF381211 0.0 100
Rhodococcus equi 1 Secretion KF410888 0.0 100
Streptomyces sp. 1 Secretion KF410891 0.0 –c
Acid-fast staining positived 2
Mycobacterium abscessus 1 Secretion JF487938 0.0 100
Mycobacterium tuberculosis 1 Sputum KF410893 0.0 100
aThe clinical isolates first reported in China.
bThe clinical isolates first reported in the international literature.
cMore than two species in the same genus with the % ID ≥ 99%.
dAll these isolates are not available to be identified by Phoneix or Microscan, and exception of these were attempted to identify by Phoneix.
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Figure 2 Fungal ITS2 PCR products of agarose gel
electrophoresis. The following DNA templates were used for PCR
(by lane): 1, Candida albicans ATCC90029; 2, Candida tropicalis
ATCC13803; 3, Candida glabrata ATCC15126; 4, Candida parapsilosis
ATCC22019; 5, Aspergillus fumigatus ATCC96918; 6, Aspergillus flavus
ATCC28539; 7, Aspergillus terreus ATCC1012; 8, Aspergillus niger
ATCC16404; 9, Cryptococcus neoformans; 10, Fusarium sp.; 11, penicilliposis
marneffei; 12, Escherichia coli ATCC25922; 13, human leucocyte.
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methods. This molecular identification method offers
numerous desirable features: (1) convenience, as common
molecular biology methods and techniques are used in the
procedure (including efficient one-step DNA extraction,
PCR, electrophoresis, commercial sequencing, and sequence
analysis); (2) Availability, as it is based on well established
theories and methods (including amplicon preparation by
PCR, commercial sequencing, and GeneBank verification);
and (3) cost-effectiveness, as the cost of the procedure can
be lower than ever for the development of information
and technology. If laboratories haven’t the extensive expert-
ise to use other methods by phenotypic criteria, the use of
the molecular methods as an alternative to identify “difficult
to identify” microbes can be considered.Table 2 ITS2-based identification of a collection of 31 fungi “
Genus/straind No. of isolates Source of isolate
Aspergillus flavus 1 Secretion
Aspergillus fumigatus 2 Sputum
Aspergillus niger 1 Sputum
Aspergillus terreus 2 Sputum, secretion
Cryptococcus neoformans 1 Blood
Exophiala jeanselmei 1 Sputum
Fusarium sp. 3 Blood, secretion
Penicillium marneffei 9 Blood, sputum, se
Phomopsis sp.a 1 Secretion
Rhizopus oryzae 1 Secretion
Rhodotorula mucilaginosa 1 Blood
Trichomonascus ciferriia 1 Secretion
Trichosporon asahii 5 Blood, urine, secr
Trichosporon asteroides 1 Blood
Trichosporon jirovecii 1 Secretion
aThe clinical isolates first reported in China.
cMore than two species in the same genus with the % ID ≥ 98%.
dAll these isolates are not available to be identified by Phoneix or Microscan.Various bacteria were identified through sequencing in
this study. The overall performance of sequence analysis
is excellent, as it enables the identification of “difficult-
to-identify” bacterial isolates. Thus, the sequencing of
16S rDNA can serve as a supplement in regular clinical
work for bacteria identification, especially for poorly de-
scribed, biochemically deficient or fastidious organisms.
However, the method does have a little potential limita-
tion that it can not identify all of bacteria successfully.
This is due to insufficient base heterogeneity in the 16S
rDNA of some organisms, resulting in the inadequate
discrimination of some species, such as Shigella sonnei
and Escherichia fergusonii [13]. In this case, epidemio-
logical, clinical, and phenotypic microbiological data of
an isolate can be collected and combined with sequence
analysis from a more variable region, such as intergenic
16S-23S rRNA spacer regions.
The conventional identification of fungi is mainly based
on a combination of morphological and biochemical
features. Morphologies at all levels require careful expert
evaluation for correct species assignment because of ex-
cessive morphological variability. Our study demonstrates
the feasibility of ITS2 sequencing for the identification of
clinically important and rare fungi. This method identified
31 isolates as 15 species or genera, including Aspergillus,
Cryptococcus, Exophiala, Rhizopus, and Trichosporon.
Almost all clinically relevant species could be identified by
ITS2 region sequencing, which is highly specific [5].
We conducted a systematic search in PubMed, GenBank,
and Chinese National Knowledge Infrastructure (CNKI)difficult-to-identify” clinical isolates
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isolates we identified. One of these rare isolates, from a
female patient with acute pancreatitis, is Agrobacterium
tumefaciens, a rod shaped, Gram-negative soil bacterium
and the causal agent of crown gall disease. Although the
international literature has reported Agrobacterium tume-
faciens in clinical catheter-related infection [14], this clin-
ical infection has not been reported in China. Another
rare isolate, from puncture fluid of a lung cancer patient
with pleural effusion, Bilophila wadsworthia, is a unique
Gram-negative anaerobic rod bacterium that has not been
reported in mainland China but in Taiwan [15]. Inter-
national literature has reported this isolate from a variety
of specimens like bile, pus, and blood [16,17]. Capnocyto-
phaga sputigena is a Gram-negative rod bacterium in the
oral flora of healthy humans that likely causes systemic
infections in immunocompromised patients with granu-
locytopenia and oral ulcerations, especially in children
[18,19]. In this study, three isolates were recovered at our
hospital from three children (under 10 years old) suffering
from lymphoblastic leukemia or thalassemia. Dialister
pneumosintes, a small, non-fermentative, Gram-negative
anaerobic rod bacterium, is considered a commensal organ-
ism of the oral cavity, nasopharynx, intestine, and vaginal
flora [20,21]. This pathogen was responsible for various
infections in immunocompromised patients [22]. A 50-
year-old woman suffering from cerebral trauma was
infected by D. pneumosintes isolated from cerebrospinal
fluid in this study. A species of Massilia, Massilia timonae,
a nonfermentative aerobic Gram-negative rod bacterium,
was isolated from the blood and CSF [23,24]. We first
reported Massilia sp. from clinical specimens in China.
Pontibacter sp. has been mainly reported in the envir-
onment, including water, garbage dumps, and soil. There
are no clinical reports on this species in the international
literature to date. Bacillus niabensis is also a species
commonly found in the environment that rarely causes
clinical infections and human colonization. Here, the
specimens from bathystixis contained B. niabensis in a
patient. The genus Janibacter is typically isolated from
sludge and the name Janibacter refers to the changing
morphology of the microorganisms during growth
[25,26]. We identified Janibacter sp. from an adult with
a fever over 38°C, indicating it may be isolated from
clinical specimens, even blood, in China. Leifsonia sp. is
an aquatic coryneform rod rarely associated with human
infections. Some species, like Leifsonia aquatica, have been
accidentally found in the clinic in other countries, but no
species previously reported in China [27-29]. We report
two cases of bloodstream infection in a female patient with
osteogenic sarcoma and a 45-day-old infant. Paenibacillus
massiliensis is a Gram-positive, facultative anaerobic rod
bacterium isolated from blood culture [30]. We are the first
to report the species from clinical specimens in China. Inthis hospital, the sample containing acid-fast bacilli will be
sent to Guangzhou Antituberculosis Station to identify the
microbes after our laboratory checks it positive by acid-
fast staining. This Mycobacterium tuberculosis in Table 1
was used to validate the molecular method of 16S rDNA
sequencing.
Phomopsis sp. is a frequent fungal parasite of plants
around the world, but only a limited number of genera
have been documented to cause human disease [31-33].
We report the first human case due to Phomopsis sp. in
China. Rhizopus oryzae can cause invasive fungal infections
called mucormycosis in humans [34]. Here we report a
serious case of disseminated type mucormycosis caused
by Rhizopus oryzae in a patient suffering diabetes with or-
bital cellulitis, which is a rare clinical case. Trichomonascus
ciferrii known as Candida ciferrii has morphological char-
acteristics that differ from more common Candida species
and is emerging as a causative agent of opportunistic
infections. This is the first case reported in China, from a
patient with chronic suppurative otitis media.
In this study, all “difficult-to-identify” isolates were
correctly identified and the etiological agent identified.
Therefore, sequencing 16S rDNA and ITS 2 region is a
good supplemental for clinical conventional methods in
the identification of microbes.
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